Efficacy of Propolis as an Adjunct to Scaling and Root planing in patients with chronic periodontitis - placebo controlled study
Efficacy of Propolis as an Adjunct to Scaling and Root planing in patients with chronic periodontitis
DOI:
https://doi.org/10.70284/njirm.v8i4.1272Keywords:
Propolis, GCF, Inteleukin -1β, Interleukin - 4, Periodontal inflammation, Chronic periodontitisAbstract
Introduction: Propolis is one of the few natural remedies that have maintained its popularity over a long period of time. It’s a natural antibiotic is a resinous substance that honey bees collect from tree buds, sap flow, shrubs and other botanic sources. Propolis is a subject of recent research in dentistry, since there is some evidence that propolis may actively protect against oral disease due to its antimicrobial, anti-inflammatory and host modulatory properties. The present research was undertaken to test the efficacy of propolis as an adjunct to SRP on clinical Parameters and cytokine levels in patients with chronic periodontitis. Methodology: 15 patients diagnosed with chronic generalized periodontitis were included in the study. Two quadrants with maximum number of sites with PPD measuring ≥ 6mm were selected from each patient. The clinical parameters like MGI, BOP, PPD, CAL were recorded for the selected quadrants in all teeth excluding third molars. 3μlitre of GCF were collected from a site with deepest probing pocket in each quadrant. Then the patients were subjected for full mouth SRP .Then each quadrant is randomly assigned for group-I and group-II. In test group, the quadrant will be subjected for Irrigation with 3mL of 30% Propolis solution per tooth on 0, 7, 15 & 21st day. In placebo group, the quadrant will be subjected for Irrigation with 3mL of distilled water per tooth on 0, 7th, 15th and 21st day. In both the groups clinical parameters and GCF collection was repeated after two months and three months. Results: Three months following nonsurgical therapy and sub-gingival irrigation of 30% propolis four times (once in every week), there was significant improvement in clinical parameters and immunological parameters i.e. IL-1β, IL-4. Conclusion: Sub gingival irrigation of 30% propolis as an adjunct to SRP is beneficial in reducing the periodontal inflammation and arresting the periodontal tissue destruction when followed up for 3 months. [Annaji S NJIRM 2017; 8(4):17-22]
References
2. Giannobile WV. Host-response therapeutics for periodontal diseases. J Periodontol 2008; 79:1592–1600.
3. Dolci P, Ozino OI. Study of the in vitro sensitivity to honey bee Propolis of Staphylococcus aureus strains characterized by different sensitivity to antibiotics. Ann Microbiol 2003;53:233-43.
4. Kosalec1 SL, Pepeljnjak S, Bakmaz M. Flavonoid analysis and antimicrobial activity of commercially available propolis products. ActaPharma 2005;55:423-30.
5. Martins RS, Pereira ES Jr, Lima SM, Senna MI, Mesquita RA, Santos VR. Effect of commercial
ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis. J Oral Sci 2002 44(1): 41-48.
6. Koc AN, Silici S, Kasap F, Hormet-oz HT, Mavus-Buldu H, Ercal BD. Antifungal Activity of the Honeybee Products Against Candida spp. and Trichosporon spp. Journal of Medicinal Food2011; 14 (1-2): 128-34.
7. Paulino N, Abreu SRL, Uto Y, Koyama D, Nagasawa H, Hori H, Dirsch VM, Vollmar AM, Scremin A, Bretz WA et al. Anti-inflammatory effects of a bioavailable compound Artepillin C in Brazilian propolis. European Journal of Pharmacology2008; 587(1-3) 296–301.
8. Ozona F, Sumerb Z, Plolatc ZA, ErdK, Ozane U, Derguf O. Effect of Mouth Rinse containing Propolis on Oral Microorganisms and Human gingival fibroblasts. European Journal of Dentistry 2007;1:195-201.
9. Murray MC, Worthington HV, Blinkhorn AS. A study to investigate the effect of propolis- containing mouth rinse on the inhibition of de novo plaque formation. J Clin Periodontol 1997;24:796-808.
10. Toker H, Ozan F, Ozer H, Ozdemir H, Eren K, Yeler HJ. A morphometric and histopathologic evaluation of the effects of propolis on alveolar bone loss in experimental periodontitis in rats. J Periodontol 2008;79:1089-94.
11. Oncag O, Cogulu D, Uzel A, Sorkun K. Efficacy of propolis as an intracanal medicament against Enterococcus faecalis. General Dentistry 2008;54:319-22.
12. Kabashima H, Nagata K, Hashiguchi I, Toriya Y, Lijima T, Maki K, Maeda K et al. Interleukin-1 receptor antagonist andinterleukin-4 in gingival crevicularfliud of patients with inflammatory periodontal disease. J Oral Pathol Med 1996; 25:449–55.
13. Sigusch B, Klinger G, Glockmann E, Simon HU. Early-onset and adult periodontitis associated with abnormal cytokine production by activated T lymphocytes. J Periodontol1998;69:1098–1104.
14. Assuma. R, Oates. T, Cochran. D, Amar. S. & Graves. D. T. IL-I and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol1998; 160: 403-09.
15. Yamamoto M, Kawabata K, Fujihashi K, Mc Ghee JR, Thomas E, Van Dyke, Bamberg TV, Hiroi T,Kiyono H et al. Absence of endogenous interlukin-4 induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases. Am J Pathol 1996; 148:331-39.
16. TaupinV,Gogusev J, Descamps- Latscha B, Zavala F:Modulation of Tumor necrosis factor –Alpha , Interleukin -1Beta, Interleukin 6, Interleukin 8and Granulocyte/Macrophage Colony Stimulating Factor Expression in Human Monocytes by an Endogenous Anxiogenic Benzodiazepine Ligand Triakontatetraneuropeptide: Evidence for a role of prostaglandins. MolPharmacol 1993;43:64-69
17. He W , Pelletier JP, Martel P J, Laufer S, Di Battista JA. Synthesis of interleukin 1 beta, tumor necrosis factor alpha and interstitial collagenase (MMP-1) is eicosanoid dependant in human osteo arthritis synovial membrane ex-plants: Interactions with anti inflammatory cytokines. J Rheumatol2002 :29: 546 – 553.
18. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. J Immunol Today 1991;12:404–10.
19. Ishihara Y, Nishihara T, Kuroyanagi T, Shirozu N, Yamagishi E, Ohguchi M, Koide M, Ueda N, Amano K, Noguchi T et al. Gingival crevicular on Interleukin-1and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodont Res 1997;32:524–29
20. Rawlinson A, Dalati MH, Rahman S, Walsh TF, Fairclough AL. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 2000;27:738–43.
21. Mathur A, Michalowicz B, Castillo M, Aeppli D. Interleukin-1α, interleukin-8 and interferon-a levels in gingival crevicular fluid. J Periodontal Res 1996;31:489– 95.
22. Yucel OO, Berker E, Gariboglu S, Otlu H. Interleukin-11, interleukin-1b, interleukin- 12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008;35:365–370.
23. Mathur A, Michalowicz B, Castillo M, Aeppli D. Interleukin-1a, interleukin-8 and interferon-a levels in gingival crevicular fluid. J Periodontal Res 1996;31:489–495.
24. Yu cel OO, Berker E, Gariboglu S, Otlu H. Interleukin-11, interleukin-1b, interleukin- 12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008;35:365–70
25. Hou LT, Liu CM, Rossomando EF. Crevicular interleukin-1β in moderate and severe periodontitis patients and the effect of phase I
periodontal treatment. J Clin Periodontol 1995;22:162–67.
26. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1b, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000;71:1535–45.
27. Torwane NA, Eshani S, Abhishek G, Malik AA, Gaurao VM, Evaluation of clinical efficacy of mouthrinse containing Indian propolis in inhibition of plaque formation and improvement of gingival health: a clinical trial. 2015;4(8)1672-83.
28. Chi-Cheng Tsai, Chia-HsinKu,Ya-Ping Ho, Kun-Yen Ho, Yi-Min Wu, and Chun-Cheng Hung, Changes in Gingival Crevicular fluid IL-4 and Interferon – Gamma in patients with chronic periodontitis before and after periodontal initial therapy. J Med Sci 2007;23:1-7
29. Koo H, Rosalen PL, Cury JA, Park YK, Ikegaki M, Sattler A. Effect of Apismellifera propolis from two Brazilian regions on caries development in salivated rats. Caries Res.1999; 33: 393-400.
30. Dodwad V, Kukreja BJ. Propolis mouthwash: A new beginning. J Indian SocPeriodontol2011; 15: 121-5.
